Pancreatic Neoplasms: all 3,311 studies
Page 25 of 34. Open to participants first (911), then studies with results posted, then the rest; newest registration first within each.
- Epidural Analgesia Use in Pancreatic ResectionsCompletedNCT02681796Phase 1
- Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic CancerTerminatedNCT02681601Not applicable
- Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)CompletedNCT02676349Phase 2
- Reliability of the Preoperative Work-up in Patients Submitted to Surgery for Cystic Neoplasms of the PancreasStatus unknownNCT02675738
- Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive MalignanciesTerminatedNCT02672917Phase 1
- Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic CancerTerminatedNCT02671890Phase 1
- Enhanced Recovery After Minimally Invasive PancreaticoduodenectomyCompletedNCT02671357
- A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Route Clinical Practice Treating Pancreatic CancerTerminatedNCT02670746
- Parenteral Nutrition in Patients With Biliopancreatic Mass LesionsCompletedNCT02670265Not applicable
- Study of SBP-101 in Pancreatic CancerCompletedNCT02657330Phase 1
- Dynamic Changes of Sera Immunoglobulin G4 and Interleukin-10 in the Patients of Pancreatic Cancer After ChemotherapyStatus unknownNCT02654288
- TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsTerminatedNCT02650635Phase 1
- Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable StudyStatus unknownNCT02646514Not applicable
- Systematic Lymph Node Sampling and Analysis in Patients With Pancreatic CancerStatus unknownNCT02646462
- A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic CancerCompletedNCT02643498Phase 1
- Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic CancersCompletedNCT02639026Phase 1
- Quality of Life After Radiofrequency Ablation of Pancreatic CancerCompletedNCT02637596Not applicable
- A Study of LY2880070 in Participants With Advanced or Metastatic CancerCompletedNCT02632448Phase 1/2
- Preoperative Nutritional Support in Malnutritional Cancer PatientsCompletedNCT02626195Not applicable
- 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer PatientsTerminatedNCT02602067Phase 1
- Intraoperative Radiation Therapy for Resectable Pancreas CancerStatus unknownNCT02599662Phase 1
- M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryActive, not recruitingNCT02595931Phase 1
- Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 CatheterCompletedNCT02591082
- Study of Neo-adjuvant RO7009789 Alone or Neo-adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine Followed by Adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine for Patients With Newly Diagnosed Resectable Pancreatic CarcinomaCompletedNCT02588443Phase 1
- Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid TumorStatus unknownNCT02587689Phase 1/2
- Prospective Phase I Study of GAX for Metastatic Pancreatic CancerWithdrawnNCT02581501Phase 1
- Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated CachexiaTerminatedNCT02580422
- A Pilot Study to Evaluate the Efficacy of ITDD vs. CMM in the Treatment of Pancreatic Cancer PainWithdrawnNCT02578459Not applicable
- Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic CancerWithdrawnNCT02575508Phase 1/2
- Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)Active, not recruitingNCT02568267Phase 2
- A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT02565641Phase 2
- First-line Treatment of Metastatic Pancreatic Cancer With Nab-paclitaxel and GemcitabineCompletedNCT02564146Phase 2
- QUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-PaclitaxelCompletedNCT02559674Phase 1
- Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic CancerCompletedNCT02558868Phase 2
- Treatment of Pancreatic Cancer With AbraxaneCompletedNCT02555813
- Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic CancerStatus unknownNCT02550847
- Dendritic Cell Vaccine and Chemotherapy for Patients With Pancreatic CancerTerminatedNCT02548169Phase 1
- A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic CarcinomaCompletedNCT02539537Phase 3
- Head to Head Comparison of Two Needles EUS Guided FNBWithdrawnNCT02534246Not applicable
- Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)Active, not recruitingNCT02531607
- Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary NeoplasmStatus unknownNCT02528526Phase 1/2
- Postoperative Stress Response in Patients Following Fast Track vs Conventional Protocol After Hepatectomy or PancreatectomyCompletedNCT02524925Not applicable
- A Phase II MULTICENTRE Trial of Needle Based Laser Confocal Endomicroscopy of Cystic and Solid Tumours of the PancreasCompletedNCT02523170Not applicable
- The Role of Muscle Cachexia in Pancreatic CancerWithdrawnNCT02515513Not applicable
- ARQ-761 Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Pancreatic CancerTerminatedNCT02514031Phase 1
- Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing SurgeryCompletedNCT02511821Not applicable
- Efficacy and Safety of PARPi to Treat Pancreatic CancerCompletedNCT02511223Phase 2
- Efficacy and Mechanisms of Acupuncture for Patients With Advanced Pancreatic Cancer PainStatus unknownNCT02510066Phase 3
- Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative ResectionStatus unknownNCT02506842Phase 3
- Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer.Status unknownNCT02506803Phase 1
- Brown Adipose Tissue Activity and Energy Metabolism in CachexiaCompletedNCT02500004Not applicable
- Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid TumorsActive, not recruitingNCT02495896Phase 1
- Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic LesionsTerminatedNCT02494388
- The Canadian/US Integrative Oncology StudyCompletedNCT02494037
- Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 ImmunostainingCompletedNCT02486497Not applicable
- A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic CancerCompletedNCT02481635Phase 1/2
- Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary CancerStatus unknownNCT02479984Not applicable
- Incretin-based Drugs and Pancreatic CancerCompletedNCT02475499
- Radiofrequency Ablation for Biliopancreatic MalignancyCompletedNCT02468076Phase 2
- Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic CancerTerminatedNCT02465983Phase 1
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active, not recruitingNCT02465060Phase 2
- Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1)Status unknownNCT02461836Phase 2
- Comparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III)CompletedNCT02460432Not applicable
- Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic CancerCompletedNCT02459652Phase 2
- Clinical Impact of EUS Elastography Mean Strain Histograms (SH) and Contrast Peak-enhancement in Focal Pancreatic Masses and Lymph NodesCompletedNCT02459041
- Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes PatientsTerminatedNCT02456051
- Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the PancreasActive, not recruitingNCT02451982Phase 2
- Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary CancerCompletedNCT02451553Phase 1
- Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung CancerStatus unknownNCT02450656Phase 1/2
- HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic CancerWithdrawnNCT02449967Phase 1/2
- Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic CarcinomaNo longer availableNCT02449135
- A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer PatientsCompletedNCT02442323Not applicable
- In Vitro Models of Liver and Pancreatic CancerStatus unknownNCT02436564
- Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior TherapyActive, not recruitingNCT02432963Phase 1
- A Study of GSK2256098 and Trametinib in Advanced Pancreatic CancerCompletedNCT02428270Phase 2
- 22 G - 25 G SINS Trial for Pancreatic MassesCompletedNCT02424838Not applicable
- Invasive Treatment of Pain Associated With Pancreatic Cancer on Different Levels of WHO Analgesic LadderStatus unknownNCT02424279Not applicable
- Low-dose Radiotherapy Plus Chemotherapy With Gem-based Doublets and Stereotactic Radiotherapy for Advanced Pancreatic CancerStatus unknownNCT02416609Not applicable
- Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based ChemotherapyWithdrawnNCT02414100
- Octreotide LAR as Maintenance Treatment for Patients With NECStatus unknownNCT02409849Phase 2
- Immunotherapy and SBRT Study in Borderline Resectable Pancreatic CancerTerminatedNCT02405585Phase 2
- Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With ChemotherapyTerminatedNCT02404363Phase 3
- Evaluating Weight Stability of Pancreatic Cancer Cachexia PatientsCompletedNCT02400398
- A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic CancerCompletedNCT02399137Phase 2
- Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT02394535Phase 1
- Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic AdenocarcinomaCompletedNCT02391662Phase 2
- Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic CancerCompletedNCT02382263Phase 1/2
- The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal SurgeryCompletedNCT02381249Not applicable
- Comparison Study in Pancreatic Fiducial PlacementWithdrawnNCT02376543Not applicable
- Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC PatientsCompletedNCT02374411
- Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic CancerCompletedNCT02358161Phase 1/2
- Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic CancerStatus unknownNCT02355119Phase 3
- FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic CancerCompletedNCT02351219Phase 2
- Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic CancerCompletedNCT02349867Phase 1
- Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic CancerCompletedNCT02347618Not applicable
- Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic CancerCompletedNCT02343835Not applicable
- A Phase II Multicentre Trial of Endoscopic Ultrasound Guided Radiofrequency Ablation of Cystic Tumours of the PancreasStatus unknownNCT02343692Not applicable
- Observational Study of Quality of Live in Patients With Metastatic Pancreatic CancerCompletedNCT02342847
- Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic CancerActive, not recruitingNCT02340117Phase 2
- Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma PatientCompletedNCT02338752Phase 1/2